Floatz logo

Cenobamate

Generalized Epilepsy

Ono Pharmaceutical Co., Ltd.Small moleculePhase 3Active
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
49/ 100
Competitive Position
95/ 100

Competitive context

5 Active assets in the Generalized Epilepsy cohort.

Asset / SponsorPhaseRating
Topiramate
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Phase 4BBB
Melatonin
All India Institute of Medical Sciences, Bhubaneswar
Phase 4BB
Clobazam
Lundbeck LLC
Phase 3BB
Diazepam
Pfizer
Phase 3B
Opakalim
Biohaven Therapeutics Ltd.
Phase 2/3B

View all 11 →

Same molecule, other indications

Cenobamate is also rated in:

focal epilepsyActive
BBB
Indicative · Phase 4
78 / 100
View asset →
idiopathic generalized epilepsyDormant
BB
Indicative · Phase 3
64 / 100
View asset →
epilepsyActive
B
Indicative · Phase 2
58 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →